PA Consulting - Bringing Ingenuity to Life

LONDON, April 16, 2024 /PRNewswire/ -- PA Consulting ('PA'), is proud to announce the publication of its 'Ingenuity Review 23'. The report sets out PA's 2023 performance and five-year growth, as well as its work with clients to successfully navigate the global shifts shaping our world. Against a backdrop of significant political, economic, and environmental change, PA has made clear progress in its vision to work with its clients to deliver exceptional insight and impact. Building a positive human future that is safer, healthier, more equitable, prosperous, and sustainable.

Key performance highlights include:

• Generated fee income of £790 million for the year ending December 2023, up 0.5% YoY
• Achieved 73 percent growth in fee income over five years
• Recommended by 97 per cent of clients
• Volunteered more than 21,000 hours of its people's skills and expertise to support local communities.

Christian Norris, CEO of PA Consulting, says: "At PA, we believe in the power of ingenuity to build a positive

human future. This is our purpose, and it guides our every action. Finding new, innovative ways to build a positive human future is more urgent than ever. I am proud of the work we have done in 2023 to achieve exactly this, bringing deep industry and technical expertise to unlock new opportunities for our clients. I continue to be inspired by our teams, whose energy, expertise, and commitment is nothing short of amazing." 

2023 HIGHLIGHTS: BUILDING A POSITIVE HUMAN FUTURE 

Breakthrough technologies made real 

Over the past year, organisations turned to PA when looking to deliver technology-enabled real-world innovation – whether the answer to their challenge required a change in strategy, a new product or service, or a wider enterprise transformation.

PA's pioneering approach can be seen in its work for Hubly Surgical, which is on a mission to transform bedside neurosurgery. In 2023, a PA designed life-saving bore drill to replace archaic and high-risk methods in intracranial surgery, received Food and Drug Administration (FDA) clearance in the US. This new-to-world neurotechnology can now be brought to market to save lives.

Innovation accelerates results 

For innovation to achieve real impact, PA believes it needs to be viewed through a full lifecycle, end-to-end lens. Understanding the impact of potential changes across a complex system is imperative to secure a rapid return on